ArticlePloS one2015

Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.

Ralf S Eschbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.